Within the last quarter, Deciphera Pharmaceuticals (NASDAQ:DCPH) has observed the following analyst ratings: In the last 3 months, 4 analysts have offered 12-month price targets for Deciphera ...
Within the last quarter, Deciphera Pharmaceuticals (NASDAQ:DCPH) has observed the following analyst ratings: In the last 3 months, 4 analysts have offered 12-month price targets for Deciphera ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results